世界のアンジオテンシンII受容体拮抗薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Angiotensin II Receptor Blockers Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-105X00955 • 出版社/出版日：GlobalInfoResearch / 2021年5月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、アンジオテンシンII受容体拮抗薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アンジオテンシンII受容体拮抗薬の種類別市場規模（アジルサルタン、カンデサルタン、エプロサルタン、イルベサルタン、ロサルタン、オルメサルタン、テルミサルタン、バルサルタン）、用途別市場規模（慢性腎不全、心不全、糖尿病性腎不全）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アンジオテンシンII受容体拮抗薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck & Co.、AstraZeneca、Novartis、Teva、Bayer、GlaxoSmithKline、Sun Pharmaceutical、Mylan ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：アジルサルタン、カンデサルタン、エプロサルタン、イルベサルタン、ロサルタン、オルメサルタン、テルミサルタン、バルサルタン ・用途別分析2016年-2026年：慢性腎不全、心不全、糖尿病性腎不全 ・アンジオテンシンII受容体拮抗薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アンジオテンシンII受容体拮抗薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アンジオテンシンII受容体拮抗薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アンジオテンシンII受容体拮抗薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アンジオテンシンII受容体拮抗薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Angiotensin II Receptor Blockers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Angiotensin II Receptor Blockers size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Angiotensin II Receptor Blockers market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Angiotensin II Receptor Blockers market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Azilsartan
Candesartan
Eprosartan
Irbesartan
Losartan
Olmesartan
Telmisartan
Valsartan

Market segment by Application can be divided into
Chronic Kidney Diseases
Heart Failure
Kidney Failure in Diabetes

The key market players for global Angiotensin II Receptor Blockers market are listed below:
Merck & Co.
AstraZeneca
Novartis
Teva
Bayer
GlaxoSmithKline
Sun Pharmaceutical
Mylan

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Angiotensin II Receptor Blockers Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Angiotensin II Receptor Blockers Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Azilsartan
1.2.3 Candesartan
1.2.4 Eprosartan
1.2.5 Irbesartan
1.2.6 Losartan
1.2.7 Olmesartan
1.2.8 Telmisartan
1.2.9 Valsartan
1.3 Market Analysis by Application
1.3.1 Overview: Global Angiotensin II Receptor Blockers Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Chronic Kidney Diseases
1.3.3 Heart Failure
1.3.4 Kidney Failure in Diabetes
1.4 Global Angiotensin II Receptor Blockers Market Size & Forecast
1.4.1 Global Angiotensin II Receptor Blockers Sales in Value (2016-2026))
1.4.2 Global Angiotensin II Receptor Blockers Sales in Volume (2016-2026)
1.4.3 Global Angiotensin II Receptor Blockers Price by Type (2016-2026) & (USD/Unit)
1.5 Global Angiotensin II Receptor Blockers Production Capacity Analysis
1.5.1 Global Angiotensin II Receptor Blockers Total Production Capacity (2016-2026)
1.5.2 Global Angiotensin II Receptor Blockers Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Angiotensin II Receptor Blockers Market Drivers
1.6.2 Angiotensin II Receptor Blockers Market Restraints
1.6.3 Angiotensin II Receptor Blockers Trends Analysis
2 Manufacturers Profiles
2.1 Merck & Co.
2.1.1 Merck & Co. Details
2.1.2 Merck & Co. Major Business
2.1.3 Merck & Co. Angiotensin II Receptor Blockers Product and Services
2.1.4 Merck & Co. Angiotensin II Receptor Blockers Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Angiotensin II Receptor Blockers Product and Services
2.2.4 AstraZeneca Angiotensin II Receptor Blockers Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Angiotensin II Receptor Blockers Product and Services
2.3.4 Novartis Angiotensin II Receptor Blockers Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business
2.4.3 Teva Angiotensin II Receptor Blockers Product and Services
2.4.4 Teva Angiotensin II Receptor Blockers Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Angiotensin II Receptor Blockers Product and Services
2.5.4 Bayer Angiotensin II Receptor Blockers Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Angiotensin II Receptor Blockers Product and Services
2.6.4 GlaxoSmithKline Angiotensin II Receptor Blockers Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Sun Pharmaceutical
2.7.1 Sun Pharmaceutical Details
2.7.2 Sun Pharmaceutical Major Business
2.7.3 Sun Pharmaceutical Angiotensin II Receptor Blockers Product and Services
2.7.4 Sun Pharmaceutical Angiotensin II Receptor Blockers Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Angiotensin II Receptor Blockers Product and Services
2.8.4 Mylan Angiotensin II Receptor Blockers Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Angiotensin II Receptor Blockers Sales by Manufacturer
3.1 Global Angiotensin II Receptor Blockers Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Angiotensin II Receptor Blockers Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Angiotensin II Receptor Blockers
3.4 Market Concentration Rate
3.4.1 Top 3 Angiotensin II Receptor Blockers Manufacturer Market Share
3.4.2 Top 6 Angiotensin II Receptor Blockers Manufacturer Market Share
3.5 Global Angiotensin II Receptor Blockers Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Angiotensin II Receptor Blockers Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Angiotensin II Receptor Blockers Market Size by Region
4.1.1 Global Angiotensin II Receptor Blockers Sales in Volume by Region (2016-2026)
4.1.2 Global Angiotensin II Receptor Blockers Revenue by Region (2016-2026)
4.2 North America Angiotensin II Receptor Blockers Revenue (2016-2026)
4.3 Europe Angiotensin II Receptor Blockers Revenue (2016-2026)
4.4 Asia-Pacific Angiotensin II Receptor Blockers Revenue (2016-2026)
4.5 South America Angiotensin II Receptor Blockers Revenue (2016-2026)
4.6 Middle East and Africa Angiotensin II Receptor Blockers Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Angiotensin II Receptor Blockers Sales in Volume by Type (2016-2026)
5.2 Global Angiotensin II Receptor Blockers Revenue by Type (2016-2026)
5.3 Global Angiotensin II Receptor Blockers Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Angiotensin II Receptor Blockers Sales in Volume by Application (2016-2026)
6.2 Global Angiotensin II Receptor Blockers Revenue by Application (2016-2026)
6.3 Global Angiotensin II Receptor Blockers Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Angiotensin II Receptor Blockers Sales by Type (2016-2026)
7.2 North America Angiotensin II Receptor Blockers Sales by Application (2016-2026)
7.3 North America Angiotensin II Receptor Blockers Market Size by Country
7.3.1 North America Angiotensin II Receptor Blockers Sales in Volume by Country (2016-2026)
7.3.2 North America Angiotensin II Receptor Blockers Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Angiotensin II Receptor Blockers Sales by Type (2016-2026)
8.2 Europe Angiotensin II Receptor Blockers Sales by Application (2016-2026)
8.3 Europe Angiotensin II Receptor Blockers Market Size by Country
8.3.1 Europe Angiotensin II Receptor Blockers Sales in Volume by Country (2016-2026)
8.3.2 Europe Angiotensin II Receptor Blockers Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Angiotensin II Receptor Blockers Sales by Type (2016-2026)
9.2 Asia-Pacific Angiotensin II Receptor Blockers Sales by Application (2016-2026)
9.3 Asia-Pacific Angiotensin II Receptor Blockers Market Size by Region
9.3.1 Asia-Pacific Angiotensin II Receptor Blockers Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Angiotensin II Receptor Blockers Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Angiotensin II Receptor Blockers Sales by Type (2016-2026)
10.2 South America Angiotensin II Receptor Blockers Sales by Application (2016-2026)
10.3 South America Angiotensin II Receptor Blockers Market Size by Country
10.3.1 South America Angiotensin II Receptor Blockers Sales in Volume by Country (2016-2026)
10.3.2 South America Angiotensin II Receptor Blockers Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Angiotensin II Receptor Blockers Sales by Type (2016-2026)
11.2 Middle East & Africa Angiotensin II Receptor Blockers Sales by Application (2016-2026)
11.3 Middle East & Africa Angiotensin II Receptor Blockers Market Size by Country
11.3.1 Middle East & Africa Angiotensin II Receptor Blockers Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Angiotensin II Receptor Blockers Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Angiotensin II Receptor Blockers Typical Distributors
12.3 Angiotensin II Receptor Blockers Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Angiotensin II Receptor Blockers Revenue by Type, (USD Million), 2021-2026
Table 2. Global Angiotensin II Receptor Blockers Revenue by Application, (USD Million), 2021-2026
Table 3. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co. Major Business
Table 5. Merck & Co. Angiotensin II Receptor Blockers Product and Services
Table 6. Merck & Co. Angiotensin II Receptor Blockers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Major Business
Table 9. AstraZeneca Angiotensin II Receptor Blockers Product and Services
Table 10. AstraZeneca Angiotensin II Receptor Blockers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Novartis Basic Information, Manufacturing Base and Competitors
Table 12. Novartis Major Business
Table 13. Novartis Angiotensin II Receptor Blockers Product and Services
Table 14. Novartis Angiotensin II Receptor Blockers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Teva Basic Information, Manufacturing Base and Competitors
Table 16. Teva Major Business
Table 17. Teva Angiotensin II Receptor Blockers Product and Services
Table 18. Teva Angiotensin II Receptor Blockers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Major Business
Table 21. Bayer Angiotensin II Receptor Blockers Product and Services
Table 22. Bayer Angiotensin II Receptor Blockers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Major Business
Table 25. GlaxoSmithKline Angiotensin II Receptor Blockers Product and Services
Table 26. GlaxoSmithKline Angiotensin II Receptor Blockers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 28. Sun Pharmaceutical Major Business
Table 29. Sun Pharmaceutical Angiotensin II Receptor Blockers Product and Services
Table 30. Sun Pharmaceutical Angiotensin II Receptor Blockers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Mylan Basic Information, Manufacturing Base and Competitors
Table 32. Mylan Major Business
Table 33. Mylan Angiotensin II Receptor Blockers Product and Services
Table 34. Mylan Angiotensin II Receptor Blockers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Angiotensin II Receptor Blockers Sales by Manufacturer (2019-2021e) & (K Units)
Table 36. Global Angiotensin II Receptor Blockers Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Angiotensin II Receptor Blockers, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Angiotensin II Receptor Blockers Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Angiotensin II Receptor Blockers Production Site of Key Manufacturer
Table 40. Global Angiotensin II Receptor Blockers Sales by Region (2016-2021e) & (K Units)
Table 41. Global Angiotensin II Receptor Blockers Sales by Region (2021-2026) & (K Units)
Table 42. Global Angiotensin II Receptor Blockers Revenue by Region (2016-2021e) & (USD Million)
Table 43. Global Angiotensin II Receptor Blockers Revenue by Region (2021-2026) & (USD Million)
Table 44. Global Angiotensin II Receptor Blockers Sales by Type (2016-2021e) & (K Units)
Table 45. Global Angiotensin II Receptor Blockers Sales by Type (2021-2026) & (K Units)
Table 46. Global Angiotensin II Receptor Blockers Revenue by Type (2016-2021e) & (USD Million)
Table 47. Global Angiotensin II Receptor Blockers Revenue by Type (2021-2026) & (USD Million)
Table 48. Global Angiotensin II Receptor Blockers Price by Type (2016-2021e) & (USD/Unit)
Table 49. Global Angiotensin II Receptor Blockers Price by Type (2021-2026) & (USD/Unit)
Table 50. Global Angiotensin II Receptor Blockers Sales by Application (2016-2021e) & (K Units)
Table 51. Global Angiotensin II Receptor Blockers Sales by Application (2021-2026) & (K Units)
Table 52. Global Angiotensin II Receptor Blockers Revenue by Application (2016-2021e) & (USD Million)
Table 53. Global Angiotensin II Receptor Blockers Revenue by Application (2021-2026) & (USD Million)
Table 54. Global Angiotensin II Receptor Blockers Price by Application (2016-2021e) & (USD/Unit)
Table 55. Global Angiotensin II Receptor Blockers Price by Application (2021-2026) & (USD/Unit)
Table 56. North America Angiotensin II Receptor Blockers Sales by Country (2016-2021e) & (K Units)
Table 57. North America Angiotensin II Receptor Blockers Sales by Country (2021-2026) & (K Units)
Table 58. North America Angiotensin II Receptor Blockers Revenue by Country (2016-2021e) & (USD Million)
Table 59. North America Angiotensin II Receptor Blockers Revenue by Country (2021-2026) & (USD Million)
Table 60. North America Angiotensin II Receptor Blockers Sales by Type (2016-2021e) & (K Units)
Table 61. North America Angiotensin II Receptor Blockers Sales by Type (2021-2026) & (K Units)
Table 62. North America Angiotensin II Receptor Blockers Sales by Application (2016-2021e) & (K Units)
Table 63. North America Angiotensin II Receptor Blockers Sales by Application (2021-2026) & (K Units)
Table 64. Europe Angiotensin II Receptor Blockers Sales by Country (2016-2021e) & (K Units)
Table 65. Europe Angiotensin II Receptor Blockers Sales by Country (2021-2026) & (K Units)
Table 66. Europe Angiotensin II Receptor Blockers Revenue by Country (2016-2021e) & (USD Million)
Table 67. Europe Angiotensin II Receptor Blockers Revenue by Country (2021-2026) & (USD Million)
Table 68. Europe Angiotensin II Receptor Blockers Sales by Type (2016-2021e) & (K Units)
Table 69. Europe Angiotensin II Receptor Blockers Sales by Type (2021-2026) & (K Units)
Table 70. Europe Angiotensin II Receptor Blockers Sales by Application (2016-2021e) & (K Units)
Table 71. Europe Angiotensin II Receptor Blockers Sales by Application (2021-2026) & (K Units)
Table 72. Asia-Pacific Angiotensin II Receptor Blockers Sales by Region (2016-2021e) & (K Units)
Table 73. Asia-Pacific Angiotensin II Receptor Blockers Sales by Region (2021-2026) & (K Units)
Table 74. Asia-Pacific Angiotensin II Receptor Blockers Revenue by Region (2016-2021e) & (USD Million)
Table 75. Asia-Pacific Angiotensin II Receptor Blockers Revenue by Region (2021-2026) & (USD Million)
Table 76. Asia-Pacific Angiotensin II Receptor Blockers Sales by Type (2016-2021e) & (K Units)
Table 77. Asia-Pacific Angiotensin II Receptor Blockers Sales by Type (2021-2026) & (K Units)
Table 78. Asia-Pacific Angiotensin II Receptor Blockers Sales by Application (2016-2021e) & (K Units)
Table 79. Asia-Pacific Angiotensin II Receptor Blockers Sales by Application (2021-2026) & (K Units)
Table 80. South America Angiotensin II Receptor Blockers Sales by Country (2016-2021e) & (K Units)
Table 81. South America Angiotensin II Receptor Blockers Sales by Country (2021-2026) & (K Units)
Table 82. South America Angiotensin II Receptor Blockers Revenue by Country (2016-2021e) & (USD Million)
Table 83. South America Angiotensin II Receptor Blockers Revenue by Country (2021-2026) & (USD Million)
Table 84. South America Angiotensin II Receptor Blockers Sales by Type (2016-2021e) & (K Units)
Table 85. South America Angiotensin II Receptor Blockers Sales by Type (2021-2026) & (K Units)
Table 86. South America Angiotensin II Receptor Blockers Sales by Application (2016-2021e) & (K Units)
Table 87. South America Angiotensin II Receptor Blockers Sales by Application (2021-2026) & (K Units)
Table 88. Middle East & Africa Angiotensin II Receptor Blockers Sales by Country (2016-2021e) & (K Units)
Table 89. Middle East & Africa Angiotensin II Receptor Blockers Sales by Country (2021-2026) & (K Units)
Table 90. Middle East & Africa Angiotensin II Receptor Blockers Revenue by Country (2016-2021e) & (USD Million)
Table 91. Middle East & Africa Angiotensin II Receptor Blockers Revenue by Country (2021-2026) & (USD Million)
Table 92. Middle East & Africa Angiotensin II Receptor Blockers Sales by Type (2016-2021e) & (K Units)
Table 93. Middle East & Africa Angiotensin II Receptor Blockers Sales by Type (2021-2026) & (K Units)
Table 94. Middle East & Africa Angiotensin II Receptor Blockers Sales by Application (2016-2021e) & (K Units)
Table 95. Middle East & Africa Angiotensin II Receptor Blockers Sales by Application (2021-2026) & (K Units)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Angiotensin II Receptor Blockers Typical Distributors
Table 99. Angiotensin II Receptor Blockers Typical Customers
List of Figures
Figure 1. Angiotensin II Receptor Blockers Picture
Figure 2. Global Angiotensin II Receptor Blockers Sales Market Share by Type in 2020
Figure 3. Azilsartan
Figure 4. Candesartan
Figure 5. Eprosartan
Figure 6. Irbesartan
Figure 7. Losartan
Figure 8. Olmesartan
Figure 9. Telmisartan
Figure 10. Valsartan
Figure 11. Global Angiotensin II Receptor Blockers Sales Market Share by Application in 2020
Figure 12. Chronic Kidney Diseases
Figure 13. Heart Failure
Figure 14. Kidney Failure in Diabetes
Figure 15. Global Angiotensin II Receptor Blockers Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 16. Global Angiotensin II Receptor Blockers Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. United States Angiotensin II Receptor Blockers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Canada Angiotensin II Receptor Blockers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Mexico Angiotensin II Receptor Blockers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Germany Angiotensin II Receptor Blockers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. France Angiotensin II Receptor Blockers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. United Kingdom Angiotensin II Receptor Blockers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Russia Angiotensin II Receptor Blockers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Italy Angiotensin II Receptor Blockers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. China Angiotensin II Receptor Blockers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Japan Angiotensin II Receptor Blockers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Korea Angiotensin II Receptor Blockers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. India Angiotensin II Receptor Blockers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Southeast Asia Angiotensin II Receptor Blockers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Australia Angiotensin II Receptor Blockers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Brazil Angiotensin II Receptor Blockers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Egypt Angiotensin II Receptor Blockers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Saudi Arabia Angiotensin II Receptor Blockers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. South Africa Angiotensin II Receptor Blockers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Turkey Angiotensin II Receptor Blockers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Global Angiotensin II Receptor Blockers Sales (2016-2026) & (K Units)
Figure 37. Global Angiotensin II Receptor Blockers Production Capacity (2016-2026) & (K Units)
Figure 38. Global Angiotensin II Receptor Blockers Production Capacity by Geographic Region: 2020 VS 2021
Figure 39. Angiotensin II Receptor Blockers Market Drivers
Figure 40. Angiotensin II Receptor Blockers Market Restraints
Figure 41. Angiotensin II Receptor Blockers Market Trends
Figure 42. Global Angiotensin II Receptor Blockers Sales Market Share by Manufacturer in 2020
Figure 43. Global Angiotensin II Receptor Blockers Revenue Market Share by Manufacturer in 2020
Figure 44. Angiotensin II Receptor Blockers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 45. Top 3 Angiotensin II Receptor Blockers Manufacturer (Revenue) Market Share in 2020
Figure 46. Top 6 Angiotensin II Receptor Blockers Manufacturer (Revenue) Market Share in 2020
Figure 47. Global Angiotensin II Receptor Blockers Sales Market Share by Region (2016-2026)
Figure 48. Global Angiotensin II Receptor Blockers Revenue Market Share by Region (2016-2026)
Figure 49. North America Angiotensin II Receptor Blockers Revenue (2016-2026) & (USD Million)
Figure 50. Europe Angiotensin II Receptor Blockers Revenue (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Angiotensin II Receptor Blockers Revenue (2016-2026) & (USD Million)
Figure 52. South America Angiotensin II Receptor Blockers Revenue (2016-2026) & (USD Million)
Figure 53. Middle East & Africa Angiotensin II Receptor Blockers Revenue (2016-2026) & (USD Million)
Figure 54. Global Angiotensin II Receptor Blockers Sales Market Share by Type (2016-2026)
Figure 55. Global Angiotensin II Receptor Blockers Revenue Market Share by Type (2016-2026)
Figure 56. Global Angiotensin II Receptor Blockers Price by Type (2016-2026) & (USD/Unit)
Figure 57. Global Angiotensin II Receptor Blockers Sales Market Share by Application (2016-2026)
Figure 58. Global Angiotensin II Receptor Blockers Revenue Market Share by Application (2016-2026)
Figure 59. Global Angiotensin II Receptor Blockers Price by Application (2016-2026) & (USD/Unit)
Figure 60. North America Angiotensin II Receptor Blockers Sales Market Share by Country (2016-2026)
Figure 61. North America Angiotensin II Receptor Blockers Revenue Market Share by Country (2016-2026)
Figure 62. North America Angiotensin II Receptor Blockers Sales Market Share by Type (2016-2026)
Figure 63. North America Angiotensin II Receptor Blockers Sales Market Share by Application (2016-2026)
Figure 64. Europe Angiotensin II Receptor Blockers Sales Market Share by Country (2016-2026)
Figure 65. Europe Angiotensin II Receptor Blockers Revenue Market Share by Country (2016-2026)
Figure 66. Europe Angiotensin II Receptor Blockers Sales Market Share by Type (2016-2026)
Figure 67. Europe Angiotensin II Receptor Blockers Sales Market Share by Application (2016-2026)
Figure 68. Asia-Pacific Angiotensin II Receptor Blockers Sales Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Angiotensin II Receptor Blockers Revenue Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Angiotensin II Receptor Blockers Sales Market Share by Region (2016-2026)
Figure 71. Asia-Pacific Angiotensin II Receptor Blockers Sales Market Share by Application (2016-2026)
Figure 72. South America Angiotensin II Receptor Blockers Sales Market Share by Country (2016-2026)
Figure 73. South America Angiotensin II Receptor Blockers Revenue Market Share by Country (2016-2026)
Figure 74. South America Angiotensin II Receptor Blockers Sales Market Share by Type (2016-2026)
Figure 75. South America Angiotensin II Receptor Blockers Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Angiotensin II Receptor Blockers Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Angiotensin II Receptor Blockers Revenue Market Share by Country (2016-2026)
Figure 78. Middle East & Africa Angiotensin II Receptor Blockers Sales Market Share by Type (2016-2026)
Figure 79. Middle East & Africa Angiotensin II Receptor Blockers Sales Market Share by Application (2016-2026)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source

---